Skip to main content
. Author manuscript; available in PMC: 2015 Nov 20.
Published in final edited form as: Leuk Lymphoma. 2015 May 12;56(10):2826–2833. doi: 10.3109/10428194.2015.1030638

Table IV.

Association of BCL2 protein expression with best response.

Biomarker Response Arm A (n = 24), n (%) Arms B + C (n = 31), n (%) Odds ratio
Low BCL2 protein PR 6 (43%) 6 (43%) 1.0
SD or PD 8 (57%) 8 (57%)
High BCL2 protein PR 3 (33%) 14 (82%) 10.89
SD or PD 7 (66%) 3 (l8%)

PR, partial response; SD, stable disease; PD, progressive disease.